Latest IR information
IR News
- 2026.02.05
- Summary of Financial Statements for the Fiscal Year Ended December 31, 2025 [Japanese GAAP] (Consolidated)
- 2026.02.02
- Notice Regarding the Monthly Exercise Status of the 58th and 65th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2026.02.02
- SymBio Announces Cooperative Agreement with the NIH to Test IV Brincidofovir for Treating Progressive Multifocal Leukoencephalopathy
- 2026.01.29
- A New Approach to Multiple Sclerosis Treatment Using IV BCV Research Results from a Collaborative Study with the U.S. NIH Published in the Journal of Clinical Investigation
- 2026.01.16
- Notice Regarding Notice of the Large Volume Exercise of the 65th Stock Acquisition Rights (with Exercise Price Revision Clauses) Issued by way of Third-Party Allotment